New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent protein

DMM Disease Models and Mechanisms

Volumn 9, Issue 4, 2016, Pages 463-471

  Diaz, Ana Isabel Garcia ^a   Moyon, Ben ^a   Coan, Philip M ^b   Alfazema, Neza ^b   Venda, Lara ^a   Woollard, Kevin ^a   Aitman, Tim ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

GFP; Rat; SHR; Transgenics; WKY

Indexed keywords

ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; TRANSPOSON;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BONE MARROW TRANSPLANTATION; CHIMERA; CRESCENTIC GLOMERULONEPHRITIS; DAUGHTER CELL; EMBRYO; EXON; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DOSAGE; GENETIC BACKGROUND; GENOME; GLOMERULONEPHRITIS; INTRAVITAL MICROSCOPY; INTRON; KIDNEY CORTEX; MALE; METABOLIC SYNDROME X; MICROINJECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RAT; SLEEPING BEAUTY TRANSPOSON GERMLINE TRANSGENESIS; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSGENE; TRANSGENICS; WISTAR KYOTO RAT; ANIMAL; ANIMAL MODEL; ANTIBODY SPECIFICITY; BLOOD; BONE MARROW CELL; CYTOLOGY; GENE EXPRESSION; GENE TRANSFER; GENETICS; LEUKOCYTE; MACROPHAGE; MAMMALIAN EMBRYO; METABOLISM; TRANSGENIC RAT; TRANSPOSON;

ANIMALS; BONE MARROW CELLS; DNA TRANSPOSABLE ELEMENTS; EMBRYO, MAMMALIAN; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; INTRAVITAL MICROSCOPY; LEUKOCYTES; MACROPHAGES; MICROINJECTIONS; MODELS, ANIMAL; ORGAN SPECIFICITY; RATS, INBRED SHR; RATS, INBRED WKY; RATS, TRANSGENIC;

EID: 84963680138     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.024208     Document Type: Article

References (62)

1. Aitman, T. J., Gotoda, T., Evans, A. L., Imrie, H., and Heath, K. E., Trembling, P. M., Truman, H., Wallace, C. A., Rahman, A., Dore, C. et al. (1997). Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat. Genet. 16, 197-201.
2. Aitman, T. J., and Glazier, A. M., Wallace, C. A., Cooper, L. D., and Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C. et al. (1999). Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21, 76-83.
3. Aitman, T. J., Dong, R., Vyse, T. J., and Norsworthy, P. J., Johnson, M. D., Smith, J., Mangion, J., Roberton-Lowe, C., Marshall, A. J., Petretto, E. et al. (2006). Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439, 851-855.
4. Aitman, T. J., and Critser, J. K., Cuppen, E., Dominiczak, A., Fernandez-Suarez, X. M., Flint, J., Gauguier, D., Geurts, A. M., Gould, M., Harris, P. C. et al. (2008). Progress and prospects in rat genetics: a community view. Nat. Genet. 40, 516-522.
5. Ammar, I., Gogol-Doring, A., Miskey, C., Chen, W., Cathomen, T., Izsvak, Z. and Ivics, Z. (2012). Retargeting transposon insertions by the adeno-associated virus Rep protein. Nucleic Acids Res. 40, 6693-6712.
6. Atanur, S. S., Birol, I., Guryev, V., Hirst, M., Hummel, O., Morrissey, C., Behmoaras, J., Fernandez-Suarez, X. M., Johnson, M. D., McLaren, W. M. et al. (2010). The genome sequence of the spontaneously hypertensive rat: analysis and functional significance. Genome Res. 20, 791-803.
7. Atanur, S. S., and Diaz, A. G., Maratou, K., Sarkis, A., Rotival, M., Game, L., Tschannen, M. R., and Kaisaki, P. J., Otto, G. W., Ma, M. C. et al. (2013). Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell 154, 691-703.
8. Barash, Y., and Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J. and Frey, B. J. (2010). Deciphering the splicing code. Nature 465, 53-59.
9. Behmoaras, J., Bhangal, G., Smith, J., McDonald, K., Mutch, B., Lai, P. C., Domin, J., Game, L., Salama, A., Foxwell, B. M. et al. (2008). Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility. Nat. Genet. 40, 553-559.
10. Behmoaras, J., and Diaz, A. G., Venda, L., Ko, J.-H., Srivastava, P., Montoya, A., Faull, P., Webster, Z., Moyon, B., Pusey, C. D. et al. (2015). Macrophage epoxygenase determines a profibrotic transcriptome signature. J. Immunol. 194, 4705-4716.
11. Bishop, J. O. and Smith, P. (1989). Mechanism of chromosomal integration of microinjected DNA. Mol. Biol. Med. 6, 283-298.
12. Charreau, B., Tesson, L., Soulillou, J.-P., Pourcel, C. and Anegon, I. (1996). Transgenesis in rats: technical aspects and models. Transgenic Res. 5, 223-234.
13. D'Souza, Z., McAdoo, S. P., Smith, J., and Pusey, C. D., Cook, H. T., Behmoaras, J. and Aitman, T. J. (2013). Experimental crescentic glomerulonephritis: a new bicongenic rat model. Dis. Model. Mech. 6, 1477-1486.
14. Ellis, J. (2005). Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 16, 1241-1246.
15. Filipiak, W. E. and Saunders, T. L. (2006). Advances in transgenic rat production. Transgenic Res. 15, 673-686.
16. Garrick, D., Fiering, S., Martin, D. I. K. and Whitelaw, E. (1998). Repeat-induced gene silencing in mammals. Nat. Genet. 18, 56-59.
17. Geurts, A. M., and Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., and Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X. et al. (2009). Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433.
18. Gill, D. R., and Smyth, S. E., Goddard, C. A., Pringle, I. A., and Higgins, C. F., Colledge, W. H. and Hyde, S. C. (2001). Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Therapy 8, 1539-1546.
19. Grabundzija, I., Irgang, M., Mates, L., Belay, E., Matrai, J., Gogol-Doring, A., Kawakami, K., Chen, W., Ruiz, P., Chuah, M. K. L. et al. (2010). Comparative analysis of transposable element vector systems in human cells. Mol. Ther. 18, 1200-1209.
20. Hakamata, Y., Tahara, K., Uchida, H., Sakuma, Y., Nakamura, M., Kume, A., Murakami, T., Takahashi, M., Takahashi, R., Hirabayashi, M. et al. (2001). Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem. Biophys. Res. Commun. 286, 779-785.
21. Hofmann, A., Kessler, B., Ewerling, S., Kabermann, A., Brem, G., Wolf, E. and Pfeifer, A. (2006). Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol. Ther. 13, 59-66.
22. Hubner, N., and Wallace, C. A., Zimdahl, H., Petretto, E., Schulz, H., Maciver, F., Mueller, M., Hummel, O., Monti, J., Zidek, V. et al. (2005). Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37, 243-253.
23. Iannaccone, P. M. and Jacob, H. J. (2009). Rats! Dis. Model. Mech. 2, 206-210.
24. Inoue, H., Ohsawa, I., Murakami, T., Kimura, A., Hakamata, Y., Sato, Y., Kaneko, T., Takahashi, M., Okada, T., Ozawa, K. et al. (2005). Development ofnew inbred transgenic strains of rats with LacZ or GFP. Biochem. Biophys. Res. Commun. 329, 288-295.
25. Ivics, Z., and Li, M. A., Mates, L., Boeke, J. D., Nagy, A., Bradley, A. and Izsvak, Z. (2009). Transposon-mediated genome manipulation in vertebrates. Nat. Methods 6, 415-422.
26. Ivics, Z., Mates, L., Yau, T. Y., Landa, V., Zidek, V., Bashir, S., Hoffmann, O. I., Hiripi, L., Garrels, W., Kues, W. A. et al. (2014). Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons. Nat. Protoc. 9, 773-793.
27. Jacob, H. J., Lazar, J., Dwinell, M. R., Moreno, C. and Geurts, A. M. (2010). Gene targeting in the rat: advances and opportunities. Trends Genet. 26, 510-518.
28. Kanno, K., Okumura, F., Toriumi, W., Ishiyama, N., Nishiyama, S. and Naito, K. (1998). Nephrotoxic serum-induced nephritis in Wistar-Kyoto rats: a model to evaluate antinephritic agents. Jpn. J. Pharmacol. 77, 129-135.
29. Katter, K., and Geurts, A. M., Hoffmann, O., Mates, L., Landa, V., Hiripi, L., Moreno, C., Lazar, J., Bashir, S., Zidek, V. et al. (2013). Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J. 27, 930-941.
30. Kim, D. W., Uetsuki, T., Kaziro, Y., Yamaguchi, N. and Sugano, S. (1990). Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91, 217-223.
31. Kioussis, D. and Festenstein, R. (1997). Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7, 614-619.
32. Kitada, K., Ishishita, S., Tosaka, K., Takahashi, R.-I., Ueda, M., and Keng, V. W., Horie, K. and Takeda, J. (2007). Transposon-tagged mutagenesis in the rat. Nat. Methods 4, 131-133.
33. Kurtz, T. W. and Morris, R. C. Jr. (1987). Biological variability in Wistar-Kyoto rats. Implications for research with the spontaneously hypertensive rat. Hypertension 10, 127-131.
34. Lepretre, F., Vasseur, F., Vaxillaire, M., Scherer, P. E., Ali, S., Linton, K., Aitman, T. and Froguel, P. (2004). A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum. Mutat. 24, 104.
35. Lois, C., and Hong, E. J., Pease, S., Brown, E. J. and Baltimore, D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872.
36. Mates, L. (2011). Rodent transgenesis mediated by a novel hyperactive Sleeping Beauty transposon system. Methods Mol. Biol. 738, 87-99.
37. Mates, L., Chuah, M. K. L., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D. P., Schmitt, A., Becker, K., Matrai, J. et al. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41, 753-761.
38. Michalkiewicz, M., Michalkiewicz, T., Geurts, A.M., Roman, R. J., Slocum, G.R., Singer, O., Weihrauch, D., Greene, A. S., Kaldunski, M., Verma, I. M. et al. (2007). Efficient transgenic rat production by a lentiviral vector. Am. J. Physiol. Heart Circ. Physiol. 293, H881-H894.
39. Mizushima, S. and Nagata, S. (1990). pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
40. Moldt, B., Miskey, C., Staunstrup, N. H., Gogol-Doring, A., Bak, R. O., Sharma, N., Mates, L., Izsvak, Z., Chen, W., Ivics, Z. et al. (2011). Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells. Mol. Ther. 19, 1499-1510.
41. Montanari, S., Wang, X.-H., Yannarelli, G., Dayan, V., Berger, T., Zocche, L., Kobayashi, E., Viswanathan, S. and Keating, A. (2014). Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein. Transgenic Res. 23, 779-793.
42. Mullins, J. J., Peters, J. and Ganten, D. (1990). Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344, 541-544.
43. Murakami, T. and Kobayashi, E. (2012). GFP-transgenic animals for in vivo imaging: rats, rabbits, and pigs. Methods Mol. Biol. 872, 177-189.
44. Okamoto, K. and Aoki, K. (1963). Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27, 282-293.
45. Park, F. (2007). Lentiviral vectors: are they the future of animal transgenesis? Physiol. Genomics 31, 159-173.
46. Popova, E., Rentzsch, B., Bader, M. and Krivokharchenko, A. (2008). Generation and characterization of a GFP transgenic rat line for embryological research. Transgenic Res. 17, 955-963.
47. Pravenec, M., and Churchill, P. C., Churchill, M. C., Viklicky, O., Kazdova, L., and Aitman, T. J., Petretto, E., Hubner, N., Wallace, C. A., Zimdahl, H. et al. (2008). Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat. Genet. 40, 952-954.
48. Remy, S., Tesson, L., Usal, C., Menoret, S., Bonnamain, V., Nerriere-Daguin, V., Rossignol, J., Boyer, C., Nguyen, T. H., Naveilhan, P. et al. (2010). New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy. Transgenic Res. 19, 745-763.
49. Sado, Y., Okigaki, T., Takamiya, H. and Seno, S. (1984). Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane. J. Clin. Lab. Immunol. 15, 199-204.
50. Sasikumar, A. N., Perez, W. B. and Kinzy, T. G. (2012). The many roles of the eukaryotic elongation factor 1 complex. Wiley Interdiscip. Rev. RNA 3, 543-555.
51. Serafini, M., Bonamino, M., Golay, J. and Introna, M. (2004). Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis. Haematologica 89, 86-95.
52. Shen, B., Zhang, J., Wu, H., Wang, J., Ma, K., Li, Z., Zhang, X., Zhang, P. and Huang, X. (2013). Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 23, 720-723.
53. Shimoyama, M., De Pons, J., Hayman, G. T., Laulederkind, S. J. F., Liu, W., Nigam, R., Petri, V., Smith, J. R., Tutaj, M., Wang, S.-J. et al. (2015). The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease. Nucleic Acids Res. 43, D743-D750.
54. Smith, J., Lai, P.-C., Behmoaras, J., Roufosse, C., Bhangal, G., McDaid, J. P., Aitman, T., and Tam, F. W., Pusey, C. D. and Cook, H. T. (2007). Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J. Am. Soc. Nephrol. 18, 1816-1823.
55. Takeuchi, K., Sereemaspun, A., Inagaki, T., Hakamata, Y., Kaneko, T., Murakami, T., Takahashi, M., Kobayashi, E. and Ookawara, S. (2003). Morphologic characterization of green fluorescent protein in embryonic, neonatal, and adult transgenic rats. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 274A, 883-886.
56. Tesson, L., Usal, C., Menoret, S., Leung, E., and Niles, B. J., Remy, S., Santiago, Y., Vincent, A. I., Meng, X., Zhang, L. et al. (2011). Knockout rats generated by embryo microinjection of TALENs. Nat. Biotechnol. 29, 695-696.
57. van den Brandt, J., Wang, D., Kwon, S.-H., Heinkelein, M. and Reichardt, H. M. (2004). Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39, 94-99.
58. Whitelaw, C. B. A., and Springbett, A. J., Webster, J. and Clark, J. (1993). The majority of G0 transgenic mice are derived frommosaic embryos. TransgenicRes. 2, 29-32.
59. Will, C. C., Aird, F. and Redei, E. E. (2003). Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol. Psychiatry 8, 925-932.
60. Wolf, D. and Goff, S. P. (2009). Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 458, 1201-1204.
61. Yamori, Y. and Okamoto, K. (1974). Spontaneous hypertension in the rat. A model for human "essential" hypertension. Verh Dtsch Ges Inn Med. 80, 168-170.
62. Zheng, C. and Baum, B. J. (2005). Evaluation ofviral and mammalian promoters for use in gene delivery to salivary glands. Mol. Ther. 12, 528-536.